Stocksigma LogoStocksigma Logo

Alembic Pharmaceuticals Clears USFDA Inspection at Vadodara Facility with Zero Observations

Alembic Pharmaceuticals has successfully completed an unannounced onsite USFDA bioequivalence inspection at its facility in Vadodara, Gujarat, with zero

Alembic Pharmaceuticals Clears USFDA Inspection at Vadodara Facility with Zero Observations

Alembic Pharmaceuticals Ltd 路 Others (Uncategorized) 路 11 Sept 2026, 5:07 pm

Alembic Pharmaceuticals Clears USFDA Inspection at Vadodara Facility with Zero Observations Alembic Pharmaceuticals has successfully completed an unannounced onsite USFDA bioequivalence inspection at its facility in Vadodara, Gujarat, with zero Form 483 observations. The inspection was conducted from 31st Aug'26 to 10th Sep'26. The clean regulatory outcome eliminates immediate US compliance risks for the bioequivalence site, supporting the company's product development pipeline and regulatory approval timelines for the US market.

Original exchange filing (PDF)

More announcements from Alembic Pharmaceuticals Ltd

All Alembic Pharmaceuticals Ltd announcements